Wall Street Zen upgraded shares of Precision Optics (NASDAQ:POCI – Free Report) to a hold rating in a report published on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Precision Optics in a research report on Wednesday, September 2nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.
View Our Latest Stock Analysis on Precision Optics
Precision Optics Price Performance
Precision Optics (NASDAQ:POCI – Get Free Report) last posted its earnings results on Monday, September 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.05. The company had revenue of $8.77 million during the quarter, compared to analysts’ expectations of $7.10 million. Precision Optics had a negative net margin of 11.51% and a negative return on equity of 23.92%.
Hedge Funds Weigh In On Precision Optics
An institutional investor recently raised its stake in Precision Optics stock. WealthTrust Axiom LLC lifted its stake in shares of Precision Optics Corp. (NASDAQ:POCI – Free Report) by 2.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 231,808 shares of the company’s stock after purchasing an additional 6,158 shares during the period. WealthTrust Axiom LLC owned approximately 3.00% of Precision Optics worth $970,000 at the end of the most recent reporting period. 13.71% of the stock is currently owned by institutional investors.
About Precision Optics
Precision Optics Corporation, Inc (NASDAQ: POCI) designs and manufactures advanced optical and imaging systems, primarily for the medical device market. The company develops products used in minimally invasive surgery, including endoscopes, surgical cameras, and specialized visualization systems that help physicians view internal anatomy during diagnostic and therapeutic procedures.
Its product portfolio includes reusable and single-use endoscopes, three-dimensional imaging systems, fluorescence imaging technologies, and custom optical components and assemblies.
Further Reading
- Five stocks we like better than Precision Optics
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.
